Accord challenges Novartis blood pressure medicine patent in UK court
Accord has begun efforts in the English courts to invalidate Novartis’s patent for blood pressure medicine ahead of an anticipated launch of its own generic medication. Over a week-long trial, Accord...To view the full article, register now.
Already a subscriber? Click here to view full article